Environmental • failure analysis & prevention • health • technology development A leading engineering & scientific consulting firm dedicated to helping.

Slides:



Advertisements
Similar presentations
Strategic Environmental Assessment: Methodology Mary M. Matthews, Ph.D. SEA Consultant for European Delegation.
Advertisements

ENTITIES FOR A UN SYSTEM EVALUATION FRAMEWORK 17th MEETING OF SENIOR FELLOWSHIP OFFICERS OF THE UNITED NATIONS SYSTEM AND HOST COUNTRY AGENCIES BY DAVIDE.
Risk Analysis Fundamentals and Application Robert L. Griffin International Plant Protection Convention Food and Agriculture Organization of the UN.
« HUMAN BIOMONITORING » Consultative Forum on Environment & Health 19th October 2005 in Luxembourg Update on developments.
Public Health Essential Service #2
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDAs website for reference purposes only. It.
Chemical Substances TLV® Committee
Integrating the gender aspects in research and promoting the participation of women in Life Sciences, Genomics and Biotechnology for Health.
Safety and Extrapolation Steven Hirschfeld, MD PhD Office of Cellular, Tissue and Gene Therapy Center for Biologics Evaluation and Research FDA.
Session A Crisis and Emergency Risk Communication* *Adapted from CDC Crisis and Emergency Risk Communication (CERC) Training.
ACGIH ® Structure Scott Merkle, CIH National Institute of Environmental Health Sciences Past-Chair, ACGIH ®
Regulatory Toxicology James Swenberg, D.V.M., Ph.D.
William H. Farland, Ph.D. Acting Deputy Assistant Administrator for Science Office of Research and Development U.S. ENVIRONMENTAL PROTECTION AGENCY Biomarkers:
Biomonitoring ….a dialogue EnviroCancer Connections-LDL February 14, 2005 Discussion Leader: Suzanne Snedeker - BCERF.
What Do Toxicologists Do?
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
BASIC PRINCIPLES IN OCCUPATIONAL HYGIENE Day CAREERS IN OCCUPATIONAL HYGIENE.
1 REACh Registration, Evaluation and Authorization of Chemicals and Restriction! Ohio Valley SOT Wednesday, August 26, 2009 REACh: The New Toxicology Frontier.
Introduction to Molecular Epidemiology Jan Dorman, PhD University of Pittsburgh School of Nursing
FAO/WHO CODEX TRAINING PACKAGE
NORA Exposure Assessment Methods Team Whitepaper Research Needs and Priorities Beth Donovan Reh National Institute for Occupational Safety and Health (NIOSH)
Internal Auditing and Outsourcing
Guidance for Industry M4S: The CTD-Safety
Corporate Social Responsibility- do we need a Statutory Instrument? Presented to the Zambia Alternative Mining Indaba conference- July 17, 2013 Sombo Chunda,
TCEQ/NUATRC Air Toxics Workshop: Session V – Human Health Effects Nathan Pechacek, M.S. Toxicology Section Texas Commission on Environmental Quality
Life Cycle Overview & Resources. Life Cycle Management What is it? Integrated concept for managing goods and services towards more sustainable production.
“Critical Path” for Food and Nutrition Science Board November 5, 2004 Alan M. Rulis.
BIOLOGIC MARKERS IN OCCUPATIONAL AND ENVIRONMENTAL MEDICINE By: Dr Chavoshi.
Food Advisory Committee Meeting December 16 and 17, 2014 Questions to the Committee Suzanne C. Fitzpatrick, PhD, DABT Senior Advisory for Toxicology Center.
Basics of OHSAS Occupational Health & Safety Management System
Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.
Professional Certificate – Managing Public Accounts Committees Ian “Ren” Rennie.
Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Science, CDER, FDA ACPS Subcommittee on Manufacturing Science: Identification and Prioritization.
Clinical Pharmacy Part 2
# 1 US Army Engineer Research and Development Center Multi-Criteria Decision Analysis and Environmental Risk Assessment for Nanomaterials Jeff Steevens.
© 2011 Underwriters Laboratories Inc. All rights reserved. This document may not be reproduced or distributed without authorization. ASSET Safety Management.
Using a Comprehensive Occupational Exposure Database to Integrate Members of the Occupational Health Team and Improve Your Occupational Health Program.
United States Department of Agriculture Food Safety and Inspection Service 1 National Advisory Committee on Meat and Poultry Inspection August 8-9, 2007.
EPA’s Strength in Both GEOSS & ESIP; Environmental Health Decisionmaking January 10, 2008 George Gray, Ph.D. Assistant Administrator EPA Office of Research.
Forging Partnerships on Emerging Contaminants November 2, 2005 John Vandenberg Associate Director for Health National Center for Environmental Assessment.
Christopher N. Greene, PhD Newborn Screening and Molecular Biology Branch, Division of Laboratory Sciences NCEH, CDC Tuesday, 28th June 2011 Molecular.
Risk Assessments: Models for Estimating the Risk of Transmitting TSE by Human Tissue Intended for Transplantation Rolf E. Taffs, Ph.D. Center for Biologics.
Major Components of FDA’s Action Plan for Acrylamide Richard Canady, PhD DABT US Food and Drug Administration Center for Food Safety and Applied Nutrition.
Preventive Emergency Planning Emergency Plans should focus not just on response but on reducing risk Emergency Planning that focuses on risk should consider.
Prof. Dr. Wolfgang Dekant Department of Toxicology University of Würzburg Germany Risk, Hazard, and Innovation.
Chapter 3 Strategic Information Systems Planning.
Biological monitoring
Environmental Risk Analysis Chapter 6 © 2007 Thomson Learning/South-WesternCallan and Thomas, Environmental Economics and Management, 4e.
Argonne National Laboratory Experience and Perspectives on Environmental Remediation Karen P. Smith Environmental Science Division Argonne National Laboratory.
Biologic Monitoring A. H. Mehrparvar, MD Occupational Medicine department Yazd University of Medical Sciences.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
HERA - CED, 30th March 2001 Communication: Objectives, Status and Activities XXXI CED Annual meeting - 30 th March Charles Laroche HERA Communication.
NUATRC/TCEQ Air Toxics Workshop October Air Toxics Air Toxics: What We Know, What we Don’t Know, and What We Need to Know Human Health Effects –
Research in the Office of Cellular, Tissue and Gene Therapies: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation.
European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.
Forging Partnerships on Emerging Contaminants November 2, 2005 Elizabeth Southerland Director of Assessment & Remediation Division Office of Superfund.
Perspective on the current state-of-knowledge of mode of action as it relates to the dose response assessment of cancer and noncancer toxicity Jennifer.
Office of Research and Development National Center for Environmental Assessment Human Health Risk Assessment and Information for SRP July 28, 2009 Reeder.
Better regulation in the Commission Jonathon Stoodley Head of Unit C.1 Evaluation, Regulatory Fitness and Performance Secretariat General of the European.
HEX-Tox paper reading Tue Hye Young Choi.
Risk Assessment: A Practical Guide to Assessing Operational Risk
New Ecological Science Advice for Ecosystem Protection The EPA Science Advisory Board (SAB) Staff Office supports three external scientific advisory committees.
Robert P. King Department of Applied Economics April 14, 2017
FIFRA SAP Meeting February 2, 2010
Biologic Monitoring A. H. Mehrparvar, MD
Biological monitoring
Beyond Science and Decisions: Problem Formulation to Dose Response
Paul Y Hamey Chemicals Regulation Division
VICH GL 54, Studies to evaluate the safety of residues of veterinary drugs in human food: General approach to establish an Acute Reference Dose (ARfD)
Presentation transcript:

environmental • failure analysis & prevention • health • technology development A leading engineering & scientific consulting firm dedicated to helping our clients solve their technical problems.

Center for Toxicology & Mechanistic Biology Emerging Issues in Industrial Hygiene – The Impact of Biomonitoring Data Sol Bobst, PhD Senior Scientist Center for Toxicology & Mechanistic Biology EXPONENT, Inc. Houston, Texas sbobst@exponent.com Tel: 832-325-5714 GSM: 281-686-6363 FAX: 832-325-5799

Biomonitoring Overview What is it? Intended Uses Interpretation TLV / BEI Evaluation Process Resources Acknowledgements

What is Biomonitoring? “Biomonitoring,” is defined in the environmental public health field as the assessment of human exposure to an environmental chemical via the measurement of that chemical, its metabolites, or reaction product(s) in human blood, milk, urine, saliva, adipose, or other tissue in individuals (in a population). Needham: Int J Hyg Env Health, 2006

Why is it important to the Practice of Industrial Hygiene? Identification Evaluation Control

Current Consensus Biomonitoring Data are being generated and published faster than regulators and professionals can analyze and interpret them. There is a need for well defined guidelines for interpreting biomonitoring data. There is a need to understand how biomonitoring data should be utilized in a risk evaluation framework for regulators and industrial stakeholders. There is a need to clearly communicate that biomonitoring data do not substantiate a human health risk and disease.

Intended Uses for Biomonitoring Provide a metric of exposure for use in risk assessment. Monitor/Idenitfy exposure trends within a population. Use available tools to provide the basis for more effective design of approved studies / risk assessments.

Use in Risk Assessment Establish & Characterize Exposure / Trends. Investigate “linkages” between exposure and adverse health effects. Facilitate Risk Management. ECOTOC Document 44, November 2005

The Challenge The Production of Biomonitoring Data, or utility of a Biomonitoring Study, often does not address all of the requirements for rigorous and effective risk evaluation. What does the data mean? How is it useful? What is inappropriate interpretation?

Issues in Biomonitoring Data Quality Interpretation Ethics Transperency Biomonitoring vs. Biomarkers

Data Quality Requirements – Must address intended use, but also evaluate potential use Methodology, Study Design, Calibrations Technical Quality

Interpretation of Biomonitoring Analytical Integrity Standardized Methodology, (local vs. international standards) Recovery, Reproducibility Accounting for false positives/contamination

Ability to Describe Exposure Requires Toxicokinetics Routes of Exposure Endogenous Contribution Pharmacokinetics/Pharmacodynamics of Absorption, Distribution, Metabolism, Excretion Genotoxic Effects Forward or Reverse Extrapolation of Dose

Exposure – Effect Continuum

Benefits of Including Biomonitoring Evaluation into Industrial HSE Policy Enhance Risk Management. Case by Case evaluation of chemical specific Biomonitoring can result in effective guidance for data development of: Animal testing Methodologies for assessing human exposure IH sampling. Save Time, Resources, Money.

Shift in Focus From External Exposure Concentrations to Internal Dose Estimation. Future Regulatory Decisions may set exposure guidelines (EPA, OSHA, TCEQ) based on BEI(s), or Biomonitoring / Biomarker indices.

Biomonitoring Interpretation in Industrial Hygiene ACGIH Process for Evaluating TLV/BEI Opportunity for Involvement http://www.acgih.org/TLV/

Interpretation Define Limitations Example – One Person – One Blood Sample – One Test!!!!! NHANES Study, CDC Account for Variability – Population Context Age, Gender, Sample Volume, Geographical Location of Sample

Biomarker Evaluation is an Important Step in Interpreting Biomonitoring Data Biomarker vs. Biomonitoring Data Biomonitoring: Arsenic in Hair (Chemical in Fluid/Tissue/Matrix) Biomarker: DNA Adduct (Metric of Metabolism / Biological Mechanism) Measure of Chemical Metabolite in Biological Fluid/Tissue. Accurate Metric for Understanding External Exposure.

Biomarker Evaluation is an Important Step in Interpreting Biomonitoring Data

Feedback What Concerns or Issues in Biomonitoring are important to you?

Public Resources for Biomonitoring ECOTOC Report NAS Report Other

ECETOC Report (European Centre for Ecotoxicology & Toxicology of Chemicals) Guidance for the Interpretation of Biomonitoring Data, Document No. 44, Brussels, November 2005. Establishes Framework for evaluating biomonitoring data for risk assessment. More Detailed Guidelines on Interpretation Examples: Parabens, Hexachlorobutadiene

NAS Report Human Biomonitoring for Environmental Chemicals (NRC – NAS 2006). Conclusions: There is a need for a consistent rationale for selecting chemicals for study based on exposure and public-health concerns. Appropriate Statistical Principles Need to be Applied when sampling populations. Recommend that biomonitoring program sponsors require planning for communication and evaluation. for any applied use.

Other Biomonitoring.info – Environmental Health Research Foundation http://biomonitoringinfo.org/ CDC – National Biomonitoring Program: http://www.cdc.gov/biomonitoring/

Acknowledgements Exponent Biomonitoring Team Angelina Duggan Elizabeth Anderson Ben Thomas Louis Bloemen Sanjeev Saraf Martin Barrie

References Guidance for the Interpretation of Biomonitoring Data, Document No. 44, Brussels, November 2005, ECOTOC. Needham, Calafat, Barr “Uses and issues in biomonitoring” Int J Hyg Environ Health 2007 May;210(3-4):229-38. Epub 2006 Dec 8. Albertini , Bird , Doerrer, Needham, Robison, Sheldon, Zenick. “The use of biomonitoring data in exposure and human health risk assessments.” Environ Health Perspect. 2006 Nov;114(11):1755-62. Doerrer “Integration of human biomonitoring exposure data into risk assessment: HSEI intiatives and perspectives Int J Hyg Environ Health 2007 210; 247-251

Report Website Links NAS Biomonitoring Report - http://books.nap.edu/openbook.php?isbn=0309102723 ECETOC Report -http://www.ecetoc.org/docsharenoframe/netservices/documents/viewpaperpublication.aspx?PortalSource=718&DocID=1058